Literature DB >> 3443140

Influence of smoking and gender on the disposition kinetics of metoprolol.

L J Schaaf1, S C Campbell, M B Mayersohn, T Vagedes, D G Perrier.   

Abstract

The purpose of this study was to examine the influence of cigarette smoking and gender on the pharmacokinetics of metoprolol. Eighteen volunteers with no evidence of clinical disease each randomly received the following doses of metoprolol tartrate: 100 mg orally, 200 mg orally and 20 mg as a constant-rate intravenous infusion over 20 min. The only significant difference between smokers (S) and nonsmokers (NS) was that S had a larger steady-state volume of distribution (3.3 vs 2.5 l/kg). There were no differences in half-life, systemic clearance or bioavailability (f). No differences were observed between males (M) and females (FM) for any of the kinetic parameters examined. Systemic bioavailability varied markedly between subjects (range: 15 to 92%). In fifteen of the eighteen subjects, f was higher after the 200-mg dose compared to the 100-mg dose. These results suggest that metoprolol may be subject to saturable presystemic elimination and extend the previous observations of Johnsson et al. [1] who showed that f increased from 31% to 46% when doses were increased from 20 to 100 mg. However, the difference in f as the dose is increased is unlikely to be clinically significant since the mean difference is smaller than the variation in f among subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443140     DOI: 10.1007/BF00637630

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  39 in total

1.  The disposition of propranolol. I. Elimination during oral absorption in man.

Authors:  D G Shand; R E Rangno
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

2.  Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.

Authors:  M S Lennard; J H Silas; S Freestone; J Trevethick
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 3.  The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

4.  Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.

Authors:  C G Regårdh; S Landahl; M Larsson; P Lundborg; B Steen; K J Hoffmann; P O Lagerström
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Smoking and drug metabolism.

Authors:  G W Dawson; R E Vestal
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

6.  On the significance of host factors that affect drug disposition.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

7.  Effects of age and smoking on the pharmacokinetics of pindolol and propranolol.

Authors:  G Hitzenberger; P Fitscha; T Beveridge; E Nüesch; W Pacha
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Bioavailability of metoprolol in young adults and the elderly, with additional studies on the effects of metoclopramide and probanthine.

Authors:  R H Briant; R E Dorrington; D G Ferry; J W Paxton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias.

Authors:  A M Barrett; V A Cullum
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

10.  Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.

Authors:  M S Lennard; G T Tucker; J H Silas; H F Woods
Journal:  Xenobiotica       Date:  1986-05       Impact factor: 1.908

View more
  3 in total

1.  Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process.

Authors:  Bipin Mistry; Nikunjkumar Patel; Masoud Jamei; Amin Rostami-Hodjegan; Marilyn N Martinez
Journal:  AAPS J       Date:  2016-06-16       Impact factor: 4.009

2.  Clinical Pharmacokinetics of Metoprolol: A Systematic Review.

Authors:  Ammara Zamir; Iltaf Hussain; Anees Ur Rehman; Waseem Ashraf; Imran Imran; Hamid Saeed; Abdul Majeed; Faleh Alqahtani; Muhammad Fawad Rasool
Journal:  Clin Pharmacokinet       Date:  2022-06-28       Impact factor: 5.577

3.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.